Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal
about
Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3.Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membranePlasma membrane is the site of productive HIV-1 particle assemblyPhosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNACharacterization of siamycin I, a human immunodeficiency virus fusion inhibitorBasic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse.Analysis of the initiating events in HIV-1 particle assembly and genome packagingOpposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA.Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.Repositioning basic residues in the M domain of the Rous sarcoma virus gag proteinEfficient HIV-1 replication can occur in the absence of the viral matrix protein.Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.Virus maturation by budding.Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.Roles played by acidic lipids in HIV-1 Gag membrane bindingDeletions in the fifth alpha helix of HIV-1 matrix block virus release.Molecular determinants that regulate plasma membrane association of HIV-1 GagCell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular bodyElectrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domaincis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA.Human immunodeficiency virus matrix tyrosine phosphorylation: characterization of the kinase and its substrate requirementsA role for two hairpin structures as a core RNA encapsidation signal in murine leukemia virus virions.Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges.Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.
P2860
Q24523051-73BF5CA0-CB63-4F13-90A9-AC426CBA1BE1Q24531508-CE5E6D06-766C-4AA4-9DE4-9C439F409288Q24563708-E9674770-FC38-476F-81AA-C8049BE6F7B1Q27334953-7CDB9F56-08CB-40D4-9FA4-0FBC21ABFE48Q28272788-EB7EF571-9CB4-4BA5-8EE7-CC3ACE30D4B0Q28379084-81167B31-5A40-4440-A7DA-1447C7E60093Q30540433-EAE1B586-E701-494F-8662-99A9C582B391Q30992792-1441759A-F3CE-4AB8-9ADD-37C7EE9757F4Q33642818-899EE301-E7F8-4CFF-B594-DC8F0BC932E2Q33647588-05A7E452-E24C-49E4-886C-94C97CD6517AQ33780632-A46AA954-708B-4922-8FD2-0C661C655349Q33782781-88236FC9-FA02-4C70-BACF-CA15B86DF91DQ33784101-66FA497D-ABAA-45B7-812D-244BC736D90EQ33784754-82D43755-E2CE-4DCC-8978-B9BCC71B75C4Q33785479-D63D4F1D-F0CD-4EFA-B4DA-E2577CD0F5E0Q33787084-83EBFDE7-39E6-439C-86C4-B93D2D05CD1EQ33794223-C468F9C3-A873-4D94-98D0-21939B34DDC2Q33800293-3EFB5F03-D312-4670-B338-29B9630DDA35Q33805303-27E4A6B3-A74A-403E-861D-A265571B8ED8Q33809649-8864BBFE-E342-41C8-B043-619BC1D53068Q33813747-2A063A21-21DF-46F5-9C6F-ED9E3FDC2BD4Q33816490-195CA799-579C-4475-88CC-E4B63AD16CF4Q33827168-1371B53A-C19E-4759-AF70-E353DCED1018Q33888825-04001EC6-761F-4A72-82FA-5431E491A9E0Q34059163-FE4D0BFA-37C5-4050-9D93-1756495EB42FQ34068037-BCD4B330-60E9-4E6B-A2E9-D1DA2F2F755EQ34302330-3B1F101A-49DA-4AC5-9CC5-09DFB170D336Q34304675-64A9A480-6ED9-433F-A062-431470417264Q34615838-3646F029-97B4-48D3-883B-80FD58D3406FQ34620716-28F447FF-B91F-4E26-AA4C-816290F84BAEQ35113734-62D5828E-F8CA-4508-A951-24DD899C873FQ35543719-F80B66E2-4316-474F-8CAE-615F90459107Q35857301-6BB9B120-933D-42B0-89AF-C576183A2CEEQ35865815-5F12E15D-8F42-4FCF-95B2-151B9498A49AQ35892051-0FF7EA16-EC94-485B-B39B-A69B318A2C92Q35896534-D8247B99-524F-430A-AE5E-658459BB6A19Q36485425-6B56D809-2BA9-401D-A0D0-0BCAE75A119FQ36748033-30142EF5-CFCA-4E37-AC72-5D1E2E593314Q36812591-EE2A624C-8413-4557-8C56-DE528714E39DQ37492757-89049F34-09FF-4B8C-A599-7D449AAED11F
P2860
Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Efficient particle formation c ...... uted by a myristylation signal
@ast
Efficient particle formation c ...... uted by a myristylation signal
@en
Efficient particle formation c ...... uted by a myristylation signal
@nl
type
label
Efficient particle formation c ...... uted by a myristylation signal
@ast
Efficient particle formation c ...... uted by a myristylation signal
@en
Efficient particle formation c ...... uted by a myristylation signal
@nl
prefLabel
Efficient particle formation c ...... uted by a myristylation signal
@ast
Efficient particle formation c ...... uted by a myristylation signal
@en
Efficient particle formation c ...... uted by a myristylation signal
@nl
P2860
P1433
P1476
Efficient particle formation c ...... uted by a myristylation signal
@en
P2093
P2860
P304
P407
P577
1994-10-01T00:00:00Z